vs

Side-by-side financial comparison of Arcturus Therapeutics Holdings Inc. (ARCT) and Heritage Distilling Holding Company, Inc. (IPST). Click either name above to swap in a different company.

Arcturus Therapeutics Holdings Inc. is the larger business by last-quarter revenue ($7.2M vs $4.7M, roughly 1.5× Heritage Distilling Holding Company, Inc.).

Arcturus Therapeutics Holdings Inc. is an American RNA medicines biotechnology company focused on the discovery, development and commercialization of therapeutics for rare diseases and infectious diseases. Arcturus has developed proprietary lipid nanoparticle RNA therapeutics for nucleic acid medicines including small interfering RNA (siRNA), messenger RNA (mRNA), gene editing RNA, DNA, antisense oligonucleotides, and microRNA.

Newport Craft Brewing & Distilling Company is a brewery and distillery located in Newport, Rhode Island. Established in 1999 as the Coastal Extreme Brewing Company, it was the first microbrewery in Newport and began distilling operations in 2006. The company produces a range of beers and spirits that are distributed in the Northeastern United States. In 2018 it adopted its current name to reflect its combined brewing and distilling operations. Newport Craft is owned by Audrain Hospitality Gro...

ARCT vs IPST — Head-to-Head

Bigger by revenue
ARCT
ARCT
1.5× larger
ARCT
$7.2M
$4.7M
IPST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARCT
ARCT
IPST
IPST
Revenue
$7.2M
$4.7M
Net Profit
$-323.7M
Gross Margin
68.5%
Operating Margin
-2622.6%
Net Margin
-6862.0%
Revenue YoY
-68.4%
Net Profit YoY
3.1%
EPS (diluted)
$-31.89

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARCT
ARCT
IPST
IPST
Q4 25
$7.2M
$4.7M
Q3 25
$17.2M
$3.0M
Q2 25
$28.3M
$1.3M
Q1 25
$29.4M
$1.1M
Q4 24
$22.8M
Q3 24
$41.7M
$1.8M
Q2 24
$49.9M
Q1 24
$38.0M
Net Profit
ARCT
ARCT
IPST
IPST
Q4 25
$-323.7M
Q3 25
$-13.4M
$196.3M
Q2 25
$-9.2M
$-7.3M
Q1 25
$-14.1M
$-3.0M
Q4 24
$-30.0M
Q3 24
$-6.9M
$-3.4M
Q2 24
$-17.2M
Q1 24
$-26.8M
Gross Margin
ARCT
ARCT
IPST
IPST
Q4 25
68.5%
Q3 25
61.3%
Q2 25
17.2%
Q1 25
24.9%
Q4 24
Q3 24
35.8%
Q2 24
Q1 24
Operating Margin
ARCT
ARCT
IPST
IPST
Q4 25
-2622.6%
Q3 25
-96.3%
-38.4%
Q2 25
-41.0%
-503.0%
Q1 25
-57.3%
-224.5%
Q4 24
-146.7%
Q3 24
-25.8%
-118.1%
Q2 24
-42.4%
Q1 24
-80.0%
Net Margin
ARCT
ARCT
IPST
IPST
Q4 25
-6862.0%
Q3 25
-78.4%
6566.2%
Q2 25
-32.4%
-551.9%
Q1 25
-47.9%
-277.8%
Q4 24
-131.8%
Q3 24
-16.6%
-194.9%
Q2 24
-34.5%
Q1 24
-70.5%
EPS (diluted)
ARCT
ARCT
IPST
IPST
Q4 25
$-31.89
Q3 25
$-0.49
$16.97
Q2 25
$-0.34
$-0.77
Q1 25
$-0.52
$-0.34
Q4 24
$-1.10
Q3 24
$-0.26
$-160.41
Q2 24
$-0.64
Q1 24
$-1.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARCT
ARCT
IPST
IPST
Cash + ST InvestmentsLiquidity on hand
$230.9M
Total DebtLower is stronger
$2.6M
Stockholders' EquityBook value
$214.0M
$98.2M
Total Assets
$271.1M
$108.8M
Debt / EquityLower = less leverage
0.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARCT
ARCT
IPST
IPST
Q4 25
$230.9M
Q3 25
$180.4M
Q2 25
$196.5M
Q1 25
$216.9M
Q4 24
$237.0M
Q3 24
$237.2M
Q2 24
$260.3M
Q1 24
$288.4M
Total Debt
ARCT
ARCT
IPST
IPST
Q4 25
$2.6M
Q3 25
$2.6M
Q2 25
$13.0M
Q1 25
$13.0M
Q4 24
Q3 24
$15.0M
Q2 24
Q1 24
Stockholders' Equity
ARCT
ARCT
IPST
IPST
Q4 25
$214.0M
$98.2M
Q3 25
$224.6M
$420.4M
Q2 25
$231.1M
$-2.9M
Q1 25
$233.8M
$-329.0K
Q4 24
$241.0M
Q3 24
$261.9M
$-34.0M
Q2 24
$258.6M
Q1 24
$264.0M
Total Assets
ARCT
ARCT
IPST
IPST
Q4 25
$271.1M
$108.8M
Q3 25
$282.3M
$482.8M
Q2 25
$309.3M
$26.5M
Q1 25
$331.8M
$27.1M
Q4 24
$344.1M
Q3 24
$370.7M
$31.1M
Q2 24
$388.6M
Q1 24
$418.8M
Debt / Equity
ARCT
ARCT
IPST
IPST
Q4 25
0.03×
Q3 25
0.01×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARCT
ARCT
IPST
IPST
Operating Cash FlowLast quarter
$-74.3M
$-7.5M
Free Cash FlowOCF − Capex
$-74.5M
FCF MarginFCF / Revenue
-1035.2%
Capex IntensityCapex / Revenue
3.2%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARCT
ARCT
IPST
IPST
Q4 25
$-74.3M
$-7.5M
Q3 25
$-17.2M
$-4.3M
Q2 25
$-5.8M
$-1.5M
Q1 25
$-35.1M
$-2.0M
Q4 24
$-284.0K
Q3 24
$-23.8M
Q2 24
$-30.1M
Q1 24
$-5.6M
Free Cash Flow
ARCT
ARCT
IPST
IPST
Q4 25
$-74.5M
Q3 25
$-17.3M
$-4.3M
Q2 25
$-1.5M
Q1 25
$-35.3M
$-2.0M
Q4 24
Q3 24
$-23.8M
Q2 24
$-30.5M
Q1 24
$-5.8M
FCF Margin
ARCT
ARCT
IPST
IPST
Q4 25
-1035.2%
Q3 25
-101.1%
-144.7%
Q2 25
-115.3%
Q1 25
-120.1%
-187.6%
Q4 24
Q3 24
-57.2%
Q2 24
-61.1%
Q1 24
-15.3%
Capex Intensity
ARCT
ARCT
IPST
IPST
Q4 25
3.2%
0.0%
Q3 25
1.1%
1.5%
Q2 25
0.0%
0.9%
Q1 25
0.5%
1.6%
Q4 24
0.0%
Q3 24
0.2%
Q2 24
0.7%
Q1 24
0.6%
Cash Conversion
ARCT
ARCT
IPST
IPST
Q4 25
Q3 25
-0.02×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARCT
ARCT

Segment breakdown not available.

IPST
IPST

Direct To Consumer$3.0M63%
Wholesale$1.2M26%
Other$517.7K11%

Related Comparisons